Flynn James E
Transaction: 07/15/2026
SELL
Change
-4,147
Price
$75.53
Filing
07/17/2026
Type
SELL
Nuvalent, Inc.
NUVL • Biotechnology
$123.96
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$9.75B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 15.27Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:42 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$123.96
Change0.00%
Shares Out78.67M
Market Cap$9.75B
Enterprise Value$8.46B
52W Range71.13 - 123.99
Beta1.14
P/E-21.67
P/B8.30
P/FCF-31.18
EV/EBITDA-23.34
EV/FCF-27.06
Price$123.96
Change0.00%
Shares Out78.67M
Market Cap$9.75B
Enterprise Value$8.46B
52W Range71.13 - 123.99
Beta1.14
P/E-21.67
P/B8.30
P/FCF-31.18
EV/EBITDA-23.34
EV/FCF-27.06
Earnings Yield-4.62%
FCF Yield-3.21%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio15.27
Quick Ratio15.27
Target$127.32
Target Upside2.71%
Target Median$124.00
Target Range122.85 - 165.00
Volume0.00
Avg Volume2.33M
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
55/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 15.27Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 19 analyst votes · 2026-09-05
71/100
Bullish
Bullish
8
Hold
11
Bearish
0
Price Target
2026-08-06
Low
$122.85
Mean
$127.32
Median
$124.00
High
$165.00
Insider Transactions
Recent executive and insider activity
⚠ 4 high-volume insider sells detected
Flynn James E
Transaction: 07/15/2026
SELL
Change
-2,717,627
Price
Not reported
Filing
07/17/2026
Type
SELL
Flynn James E
Transaction: 07/15/2026
SELL
Change
-3,444
Price
$124.00
Filing
07/17/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Flynn James E | SELL | -4,147 | $75.53 | 07/15/2026 | 07/17/2026 |
| Flynn James E | SELL | -2,717,627 | Not reported | 07/15/2026 | 07/17/2026 |
| Flynn James E | SELL | -3,444 | $124.00 | 07/15/2026 | 07/17/2026 |
| Flynn James E | SELL | -650,000 | $124.00 | 07/15/2026 | 07/17/2026 |
| Wheeler Cameron | SELL | -3,444 | Not reported | 07/15/2026 | 07/15/2026 |
| Wheeler Cameron | SELL | -5,146 | $124.00 | 07/15/2026 | 07/15/2026 |
| Wheeler Cameron | SELL | -4,147 | $75.53 | 07/15/2026 | 07/15/2026 |
| Bogle Grant C. | SELL | -4,147 | $75.53 | 07/15/2026 | 07/15/2026 |
| Bogle Grant C. | SELL | -5,577 | Not reported | 07/15/2026 | 07/15/2026 |
| Bogle Grant C. | SELL | -3,714 | $124.00 | 07/15/2026 | 07/15/2026 |
| Protopapas Anna | SELL | -5,146 | $124.00 | 07/15/2026 | 07/15/2026 |
| Protopapas Anna | SELL | -4,147 | $75.53 | 07/15/2026 | 07/15/2026 |
| Protopapas Anna | SELL | -3,444 | Not reported | 07/15/2026 | 07/15/2026 |
| Miller Deborah Ann | SELL | -18,534 | $124.00 | 07/15/2026 | 07/15/2026 |
| Miller Deborah Ann | SELL | -17,500 | $106.82 | 07/15/2026 | 07/15/2026 |
| Miller Deborah Ann | SELL | -41,100 | Not reported | 07/15/2026 | 07/15/2026 |
| Miller Deborah Ann | SELL | -14,350 | Not reported | 07/15/2026 | 07/15/2026 |
| Porter James Richard | SELL | -121,350 | Not reported | 07/15/2026 | 07/15/2026 |
| Porter James Richard | SELL | -203,529 | $124.00 | 07/15/2026 | 07/15/2026 |
| Porter James Richard | SELL | -46,250 | $106.82 | 07/15/2026 | 07/15/2026 |